Twin-to-Twin Transfusion Syndrome (TTTS): Diagnosis, Staging & Treatment
TTTS affects 10–15% of monochorionic-diamniotic (MCDA) twin pregnancies. Unbalanced anastomoses cause net blood transfer from donor → recipient.
Pathophysiology
- Donor: Hypovolemia → oliguria → oligohydramnios, growth restriction, anemia.
- Recipient: Hypervolemia → polyuria → polyhydramnios, polycythemia, cardiac strain → hydrops.
Quintero Staging (I–V)
- I: Discordant fluid only.
- II: Donor bladder not visible.
- III: Abnormal Dopplers (absent/reversed end-diastolic velocity in UA, reversed DV flow, pulsatile UV).
- IV: Recipient hydrops.
- V: Demise of one/both twins.
Treatment
- Stage I: Surveillance (some regress).
- Stage II–IV: Fetoscopic laser photocoagulation of communicating vessels (Solomon or selective technique) — gold standard. Survival: 70–85% ≥1 twin; 50–60% dual.
- Amnioreduction: Palliation for early GA (<16w) or if laser unavailable; serial reductions.
- Selective reduction: Radiofrequency ablation/cord coagulation if severe discordance/anomaly.
- Delivery: If ≥28–30w with severe disease.
Monitoring
- Weekly ultrasound from 16w in MCDA twins (fluid, bladders, Dopplers, growth).
- Post-laser surveillance for TAPS, recurrence.
Early referral to fetal therapy center optimizes outcomes.
Infertility - Related Articles
- Understanding Blocked Fallopian Tubes: Causes, Symptoms & Treatments
- Sterility: Definition, Methods, and Importance in Healthcare
- Empty Amniotic Sac (Anembryonic Pregnancy/Blighted Ovum): Causes, Diagnosis & Management
- Twin Pregnancy Duration: Average Gestation, Preterm Risk, and Delivery Planning
- The Impact of Daily Intimacy: Exploring the Benefits of Frequent Sex in Marriage
- Fertility Drugs: Understanding Long-Term Risks & Multiple Births
- Ovarian Follicle Ovulation: The 400–500 Eggs Released in a Lifetime
